SCHEDULE: Dodge & Cox Discloses 3.9% Stake in CVS Health

Dodge & Cox has reported beneficial ownership of 50,012,765 shares, representing 3.9% of CVS Health Corporation's common stock, as of June 30, 2026.

Summary

• Dodge & Cox, an investment management firm, has filed a Schedule 13G, indicating their beneficial ownership of CVS Health Corporation's common stock.
• As of June 30, 2026, Dodge & Cox holds 50,012,765 shares, which constitutes 3.9% of the total class of securities.
• The filing confirms sole voting power over 47,541,860 shares and sole dispositive power over all 50,012,765 shares.
• This filing is an amendment (Amendment No. 1) to a previous filing.
• Dodge & Cox certifies that these securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant but not controlling stake in CVS Health Corporation by Dodge & Cox, reflecting a standard institutional investment position.

Positives

• Dodge & Cox, a significant investment manager, holds a substantial stake in CVS Health, suggesting confidence in the company's long-term prospects.
• The filing clearly outlines Dodge & Cox's voting and dispositive power, providing transparency to the market.
• The ownership percentage of 3.9% indicates a significant investment without crossing into controlling interest, which is typical for institutional investors.

Negatives

• The filing does not contain any negative information regarding CVS Health Corporation itself, as it is a disclosure of ownership by an external entity.
• The filing is an amendment, implying previous filings were made, but the specific details of prior holdings or changes are not detailed within this document.

Risks

• The primary risk associated with this filing is the potential for significant share sales by Dodge & Cox, which could impact CVS Health's stock price, although this is not indicated as their intention.
• As an institutional investor, Dodge & Cox's investment strategy could change, leading to divestment, which would be a risk for CVS Health's stock performance.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from CVS Health Corporation. It is a disclosure of beneficial ownership by Dodge & Cox.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that institutional ownership, as disclosed in Schedule 13G filings, is a common indicator of investor sentiment towards a company. A significant stake by a reputable firm like Dodge & Cox can be seen as a positive signal, though it is important to distinguish between investment holdings and activist intentions.

Comparison to Industry Standards

• Schedule 13G filings are standard for institutional investors holding more than 5% of a company's stock, or for those who acquire a significant stake but do not intend to influence control. Dodge & Cox's filing at 3.9% is below the 5% threshold for mandatory filing under Rule 13d-1(b) if they were not an 'investment adviser' or similar entity, but their reporting indicates they are acting as such.
• The ownership percentage of 3.9% is a common level for large institutional asset managers like BlackRock, Vanguard, or State Street, who often hold significant but non-controlling stakes across a broad range of companies.
• The certification that shares are held in the ordinary course of business is a standard declaration for passive investors, differentiating them from activist investors who might file a Schedule 13D.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding a significant institutional investor's holdings, which can influence market perception and potentially stock price.
• CVS Health Management: The filing confirms that Dodge & Cox does not intend to influence control, which may be reassuring to management.
• Creditors: While not directly impacted, a stable institutional investor base can contribute to overall company stability.

Next Steps

• Dodge & Cox will continue to hold its shares in CVS Health Corporation.
• Dodge & Cox may update its holdings in future filings if there are material changes.
• CVS Health Corporation will continue its business operations as usual, subject to market conditions and strategic initiatives.

Key Dates

Keywords

CVS Health, Dodge & Cox, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Institutional Investor